Related Experiment Video
Updated: Jan 23, 2026

Simple and Effective Administration and Visualization of Microparticles in the Circulatory System of Small Fishes Using Kidney Injection
Published on: June 17, 2018
Administration of a long-acting antipsychotic injection to a child while managing contraindicated polypharmacy
Gazala Akram1, Fiona Mitchell2
1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Insights
Second-generation antipsychotics, like aripiprazole long-acting injection, can treat complex child psychiatric conditions. This case highlights managing polypharmacy and inter-agency collaboration in child mental health services.
Area of Science:
- Child and Adolescent Psychiatry
- Pharmacology
- Neurodevelopmental Disorders
Background:
- Second-generation antipsychotics (SGAs) manage psychiatric symptoms and behavioral issues in neurodevelopmental disorders.
- Long-acting injectable (LAI) SGAs face reluctance in child psychiatry services.
- Polypharmacy presents challenges, including potential drug interactions.
Observation:
- A 12-year-old child required aripiprazole long-acting injection for complex psychiatric symptoms.
- The patient's medication regimen involved polypharmacy, raising concerns about CYP P450 enzyme interactions.
- Inter-sectoral and inter-agency collaboration proved challenging.
Findings:
- Aripiprazole LAI was successfully initiated in a pediatric case despite polypharmacy concerns.
- The case underscores the complexity of managing medication interactions in pediatric patients.
- Navigating multi-agency work in child mental health services requires careful coordination.
Implications:
- This case supports the judicious use of aripiprazole LAI in pediatric psychiatry under specific circumstances.
- It emphasizes the need for vigilant monitoring of polypharmacy and potential drug interactions in children.
- Continuous Professional Development is crucial for child and adolescent mental health services nursing staff to manage complex cases and inter-agency collaboration effectively.
Abstract:
Second-generation antipsychotics are used to treat a variety of psychiatric symptoms and illnesses as well as the behavioural aspects of various neurodevelopmental disorders. However, there is reluctance in using second-generation long-acting injectable antipsychotics in child psychiatry services. We present a case of a 12-year-old child whose presentation and medication regime warranted the use of aripiprazole long-acting injection against a backdrop of potential CYP P450 enzyme interactions as a consequence of polypharmacy. The case also describes the difficulties encountered working across different health sectors and agencies and highlights the ongoing need for skills-based Continuous Professional Development for Child and Adolescent Mental Health Services-based nursing staff.
More Related Videos
Related Concept Videos
Phase Transitions
Properties of Transition Metals
Forces Acting on Chromosomes
Microtubules and motor proteins exert two types of forces on...
Cooperative Allosteric Transitions
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...

